key: cord-0726507-o813euie
authors: Huang, Xiaowen; Hussain, Basharat; Chang, Junlei
title: Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
date: 2020-12-30
journal: CNS Neurosci Ther
DOI: 10.1111/cns.13569
sha: feb04a32a43f97d2491811f6b4690443e1576548
doc_id: 726507
cord_uid: o813euie

The blood–brain barrier (BBB) is an important physiological barrier that separates the central nervous system (CNS) from the peripheral circulation, which contains inflammatory mediators and immune cells. The BBB regulates cellular and molecular exchange between the blood vessels and brain parenchyma. Normal functioning of the BBB is crucial for the homeostasis and proper function of the brain. It has been demonstrated that peripheral inflammation can disrupt the BBB by various pathways, resulting in different CNS diseases. Recently, clinical research also showed CNS complications following SARS‐CoV‐2 infection and chimeric antigen receptor (CAR)‐T cell therapy, which both lead to a cytokine storm in the circulation. Therefore, elucidation of the mechanisms underlying the BBB disruption induced by peripheral inflammation will provide an important basis for protecting the CNS in the context of exacerbated peripheral inflammatory diseases. In the present review, we first summarize the physiological properties of the BBB that makes the CNS an immune‐privileged organ. We then discuss the relevance of peripheral inflammation‐induced BBB disruption to various CNS diseases. Finally, we elaborate various factors and mechanisms of peripheral inflammation that disrupt the BBB.

The circulatory system contains blood vessels that distribute blood with nutrients and oxygen and remove waste products and CO 2 from the tissue. Its normal function is essential for maintaining homeostasis of the organism. The inner layer of blood vessels is made of vascular endothelial cells (ECs). 1 The endothelium is distinct in structure and function, and can be continuous non-fenestrated, continuous fenestrated, or discontinuous dependent on the organ requirements. 2 The brain and spinal cord comprise central nervous system (CNS) that controls critical functions of the body. CNS vasculature has a unique anatomy and physiology making the CNS a socalled "immune-privileged" organ, although this idea was challenged in the past several decades. 3 Located between the CNS tissue and a kind of protective response of the body against multiple insults.

Since the BBB is highly susceptible to the inflammatory stimuli, inappropriate peripheral inflammation such as lipopolysaccharide (LPS) can impact the BBB function via different pathways. [6] [7] [8] In this review, we briefly describe current understandings on BBB structure and functions. Particularly, we elaborate the most recent advances in mechanisms of BBB disruption secondary to peripheral inflammatory conditions, which have been largely overlooked in the research of CNS diseases.

The neurovascular unit (NVU) usually consists of endothelial cells, mural cells (i.e., vascular smooth muscle cells and pericytes), basement membrane, glia cells (astrocytes and microglia cells), and neurons, which collectively contribute to BBB integrity. 9 ECs form the inner lining of all blood vessels. BBB ECs are quite different in structure and function from those in other tissues, and the typical characteristics that distinguish them from other ECs include the following: (a) paracellular transport of solutes is blocked due to tight junctions, (b) fenestrations are absent and transcytosis are reduced, limiting transcellular transport of solutes, (c) for transfer of required solutes from the blood to parenchymal cells of the brain, specific transporters, such as GLUT1 (glucose transporter 1), are expressed, (d) to remove toxic substances from CNS parenchymal cells, specific pumps, such as P-glycoprotein (P-gp), are expressed, (e) the low expression level of leukocyte adhesion molecules (LAMs) in BBB endothelial cells helps restrict entry of immune cells into the CNS, and (f) ECs of the BBB harbor more mitochondria than of other tissues, which might be related to providing the energy that ionic transport requires ( Figure 1 ). 4,10-13 These features of the CNS ECs contribute to highly selected movement of solutes in and out of the CNS parenchyma, maintaining a stable microenvironment for proper neuronal function. 14 Pericytes cover the CNS capillaries and regulate vascular stability, diameter, cerebral blood flow, and extracellular membrane protein secretion. 15 Astrocytes span around the vascular endothelium and pericytes via end-feet, and they are in contact with neurons and regulate BBB permeability. 16, 17 Microglial cells are a component of the NVU, but the link between microglial cells and BBB ECs and its effect on formation and regulation of BBB properties remains to be fully explored. 18 Furthermore, the BBB is composed of non-cellular elements, the extracellular membrane (ECM). All of these cellular and non-cellular components together maintain the BBB structural and functional integrity ( Figure 1 ).

The complex cellular and non-cellular components of the BBB collaboratively maintain the BBB function, and impairment in any one of these elements can lead to BBB disruption. 3 For example, the endothelial tight junctions (TJs) and lack of fenestrae contribute to a physical barrier, leaving carriers and/or receptors the only means for protein transportation into the CNS. 19, 20 ECs play an important role in vascular biology, such as maintaining permeability, homeostasis, and vessel wall integrity and preventing thrombosis. 3 Pericytes help preserve the TJs of ECs (e.g., Claudin-5, Occludin, and ZO-1) and regulate transcytosis in ECs, maintaining the integrity and normal permeability of the BBB. 19, 21, 22 Astrocytes secrete factors that are key to maintain BBB properties, including sonic hedgehog (Shh), vascular endothelial growth factor (VEGF), angiopoietins-1 (Ang-1), angiotensin-converting enzyme-1 (ACE-1), glial-derived neurotrophic factor (GDNF), and apolipoprotein E (ApoE). 7 ECM is a dynamic component of the BBB, and regulates BBB structure and function by impacting cell-cell and cell-matrix interaction within the NVU. 23 Microglia cells are known as the immune cells in the CNS. They can be activated and categorized into two opposite types: M1 and M2, which produce either cytotoxic or neuroprotective effects. 18 Under inflammatory conditions, they can be activated to M1 or M2 phenotype, thus damaging or protecting the BBB integrity. 24 

Both preclinical and clinical studies have found that peripheral inflammation in the form of infection is a common contributing factor for the development and deterioration of CNS diseases, such as neurodegenerative diseases AD, PD, MS, and stroke. A possible explanation is that BBB disruption in infections increases the susceptibility to CNS diseases. 27 In AD patients, peripheral inflammation increases the level of amyloid beta (β-amyloid) in the brain. 28 In amyloid precursor protein (APP) transgenic mice, peripheral injection of LPS increased BBB permeability, allowing for infiltration of peripheral proinflammatory factors such as IL-6 and TNF-α, and promoting neurological inflammation and disease progression. 29,30 LPS-induced BBB disruption also plays an important role in the transmission of Tau, probably in a non-microglia-dependent pathway. 31 Aside from AD, evidence also showed peripheral inflammation as a potential risk factor for PD and other neurodegenerative disease. 32, 33 Likewise, dysregulated systemic inflammation is present in PD, as evidenced by high levels of IL-1β, IL-2, TNF-α, CD4 + and CD8 + T lymphocytes in both serum and cerebrospinal fluid. 34 In the pathogenesis of MS, one of the most important mechanisms is the infiltration of autoreactive CD4 + T cells and other white cells into the CNS, whereas the degree of BBB destruction in experimental autoimmune encephalomyelitis (EAE) model is strongly correlated with disease severity. 35 Ischemic and hemorrhagic stroke also presents with BBB disruption, and experimental models and clinical observations together have shown that peripheral inflammation (e.g., LPS, anaphylaxis, and infection) is more likely to aggravate BBB disruption and even worsen the outcome of stroke. [36] [37] [38] [39] For example, the adaptive immune system is activated following cerebral ischemia, and the peripheral immune cells, such as T cells and B cells, rapidly infiltrate the diseased brain and release various cytokines, including pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) leading to blood vessels and BBB damage, and anti-inflammatory cytokines (IL-13, IL-10, IL-4, TGF-β) extenuating the ischemic injury. [40] [41] [42] Moreover, both immune cells and cytokines induce immunodepression after stroke, which leads to an increased incidence of infections such as pneumonia. [43] [44] [45] It is not exactly clear whether BBB dysfunction induced by inflammation is the cause or complication of CNS disease, and further study to understand the role of peripheral inflammation on BBB function and the influence on CNS disease can provide a basis for clinical treatment of the disease to a certain extent.

In December of 2019, a case of pneumonia caused by a novel coronavirus, SARS-CoV-2, emerged in Wuhan, China, and rapidly spread around the world. This new disease is termed coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). The most common symptoms of COVID-19 are fever, cough, and tiredness. 46 As for its CNS symptoms, according to a retrospective, observational case series of 214 patients, 24.8% of them had CNS manifestations, including ataxia, impaired consciousness, dizziness, and headache. 47 The most severe cases were 4 with ischemic stroke and 1 with cerebral hemorrhage who died of respiratory failure. 47 Inflammatory storm is considered one of the causes of death in severe and critical COVID-19 cases, with over half of which have lymphopenia and a cytokine storm. 48 Consistently, an increased release of cytokines (IL-1β, IL1RA, IL-6, TNF-α) and chemokines (CCL2, CCL3, CCL5) occurred after infection. [49] [50] [51] Conceivably, anakinra (IL-1 blockade) and tocilizumab (IL-6 receptor blockade) are showing significant survival benefits in COVID-19 patients with hyperinflammation. 52 F I G U R E 1 Schematic diagram of the physiological characteristics of the BBB. GLUT1, glucose transporter 1; LAMs, leukocyte adhesion molecules Although the incidence of CNS complications is high in SARS-CoV-2 infections, the pathogenesis is barely known for now. Some researchers believe the cytokine storm during infection persistently affects the CNS. 53 It is highly likely that BBB disruption might play an important role in the CNS complications associated with COVID-19. 54 However, more solid and direct evidence is needed to prove it.

Chimeric antigen receptor (CAR)-T cell therapy is a rapidly developing novel strategy for acute lymphoblastic leukemia (ALL) or chronic lymphocytic leukemia (CLL). [55] [56] [57] [58] Currently approved CAR-T therapies targeting CD19 showed profound therapeutic effects in ALL. 59 However, the toxic effects of CAR-T cells are worrying. The most important and common toxic effects are cytokine release syndrome (CRS) and the associated neurotoxicity, with the most severe of which being lethal cerebral edema. 59-64 CD3 + T cells, CD19 + B cells, and high levels of cytokines (IFN-γ, IL-6) were detectable in the cerebrospinal fluid (CSF) in ALL patients complicated with cerebral edema as soon as a few hours after CD19 CAR-T cell infusion. This was accompanied by cerebral CRS, probably due to the cytokines produced by BBB-penetrating CAR-T cells. 65 Moreover, cytokines such as IL-6, IFN-γ, and TNF-α were known to directly activate endothelial cells. Patients with severe neurotoxicity showed evidence of endothelial activation, characterized by increased BBB permeability, serving as another important mechanism for neurotoxicity in CAR-T cell treatment. 66, 67 More recently, researchers reported high CD19 expression in human brain mural cells, but not in mouse mural cells, and that is a possible on-target mechanism for CD19 CAR-T cell-mediated neurotoxicity, meanwhile suggesting limitations in preclinical animal models of neurotoxicity. 68 Thus far, the mechanisms through which CAR-T cells cause BBB dysfunction and neurotoxicity remain enigmatic. Nevertheless, it is believed to be closely related to the peripheral inflammatory responses. More in-depth studies are needed to increase the safety of CAR-T cell therapy in clinical applications.

Peripheral inflammation is basically a protective response for the organism. However, excessive and dysregulated inflammation leads to adverse effects. For example, various non-neurological systemic infections often come with CNS dysfunction, such as pneumonia and urinary systemic infection, which may be a result of chronic CNS disease. 69, 70 The BBB protects the CNS from potential peripheral insults; therefore, damaging the BBB is considerably harmful to the CNS. Discussed below are mechanisms on how peripheral inflammation impacts the BBB (Figure 2 ).

TJs are vital components that maintain BBB integrity and normal functioning, such that TJ changes directly lead to BBB disruption.

Lots of bacterial and viral infections cause degradation or disorganization of TJs indirectly through diverse pathways. [71] [72] [73] For example, cytokines including IL-1β, IL-6, IL-9, IL-17, IFN-γ, TNF-α, and CCL2, can lead to reduced TJ expression or false TJ allocation. [74] [75] [76] [77] [78] [79] Claudin-5 among others is the most important TJ protein responsible for selective permeability of the BBB, and inflammation leads to its downregulation and BBB disruption. 80 In old mice, LPS-mediated peripheral inflammation resulted in the degeneration of TJ proteins, including claudin-5. 81 On the other hand, IL-1β led to a discontinuous distribution of claudin-5 along the plasma membrane of brain endothelial cells. 75 Apart from claudin-5, LPS-induced systemic inflammation was also associated with degradation of occludin. 82 Another recent study showed that peripheral cytokines reduced expression of ZO-1 in mice with pre-existing tumors. 83 Nowadays, changes in TJs are usually used as indicators of BBB dysfunction. However, there are indirect causes for changes in TJs, such as MMPs, nitric oxide (NO), reactive oxygen species (ROS), Rho-kinase (ROCK), and NF-κB signaling pathways. [84] [85] [86] [87] [88] The specific mechanisms will be discussed below. 

Astrocytes play a vital role in maintaining BBB integrity and regulating its function. Depending on the immune trigger or the phase of inflammation, they produce either pro-or antiinflammatory mediators that affect BBB permeability and infiltration of peripheral immune cells. 96 Under an inflammatory condition, astrocytes secrete VEGF-A, which activates the eNOS signaling in ECs and downregulates the expression of occludin and claudin-5, resulting in easy entry of peripheral lymphocytes into the CNS. 97, 98 It has been reported that during inflammation astrocytes altered claudin-5 expression likely by upregulating the immune-related GTPase family M-1 protein (IRGM-1) in the EAE mouse model. 99 In middle cerebral artery occlusion (MCAO) model, researchers found high IL-9 expression in peripheral blood and IL-9 receptors on astrocytes, and further study revealed that IL-9 enhances the permeability of the BBB by promoting the secretion of VEGF-A from astrocytes. 76 Peripheral inflammation induced by LPS can cause proliferation and activation of astrocytes, changes in the end-feet structure and altered expression of other related gene, which collectively and indirectly lead to destruction of the BBB. 100, 101 Microglia cells are part of the NVU, but their interaction with BBB ECs and effects on BBB properties are not well known as mentioned above. Even so, there is evidence that shows inflammation-activated microglia contribute to BBB disruption. 102 There are two pathways for microglia activation: the M1 proinflammatory pathway and M2 antiinflammatory pathway. 103 M1 microglia contribute to BBB dysfunction and vascular "leak" mainly through production of proinflammatory mediators, promotion of immune cell trafficking, and oxidative stress. 18, 104 The proinflammatory signaling in M1 microglia involves toll-like receptor (TLR)-4, 25,105 the IFN-γ receptor complex, 106 the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor, 107 and COX2. [108] [109] [110] The secretion of TNF-α, IL-1β, IL-6, IL-12, CCL2, and CXCL10 is shown to change TJs (claudin-5, occludin, ZO-1, and ZO-2) and critical BBB transporters like P-gp proteins. 18, 26, 102, [111] [112] [113] [114] Besides, the chemokines CCL2 and CXCL10 promote trafficking of immune cells cross the BBB, including monocytes and macrophages, which is observed in stroke. 115, 116 In addition to cytokines and chemokines, there is ROS production and oxidative stress in M1 microglia, and it is related to increased expression of iNOS during peripheral inflammation induced by LPS, and also stroke. 117, 118 Different from M1 microglia, M2 microglia play protective roles in BBB disruption, including immune regulation, inflammation dampening, and repair/injury resolution. 119, 120 The polarization to M2 microglia is mediated by IL-4 receptor, FCγ receptor, IL-10 receptor, and VEGFR2 signaling. 119,121 M2 microglia mainly produce antiinflammatory mediators such as TGF-β1, IL-10, and IL-4 122, 123 Receptors for TGF-β1 are expressed at BBB and TGF-β1 may have significant positive effects on BBB integrity via activin receptor-like kinase (ALK)-1 and −5 signaling. 124 IL-10 secretion and IL-10 receptor promote inflammation suppression and migration of regulatory T cells that alleviate brain injury. 119, 125 In fact, microglia are highly dynamic and their transition from M1 to M2 is complicated and not known clearly. A latest research gave more profound evidence that microglia play a dual role in maintaining BBB integrity in distinct time course of peripheral inflammation. 24 Initially, brain microglia migrate to cerebral vessels in response to CCL5 and express claudin-5, thus maintain BBB integrity, whereafter they transform into another phenotype that contributes to BBB leakage. 24 Other type of immune cells-myeloid cells such as neutrophils, monocytes, dendritic cells (DCs), and mast cells, also influence BBB function via distinct mechanisms. Neutrophils produce a variety of proinflammatory cytokines that affect BBB function, including IL-1β, TNF-α, IL-6, IL-12, and IFN-γ, whereas TNF-α can further induce the recruitment of neutrophils to the CNS. [144] [145] [146] Additionally, when neutrophils transmigrate into the CNS, they secret IL-1 and activate the antigen-presenting cells (APC) locally, which subsequently activate endothelial IL-1R1 signaling that induces T cell recruitment and exacerbates CNS inflammation. 147 Monocytes may migrate across the BBB depending on the upregulation of cytokines (IL-1) and junction molecules (ALCAM, JAM-A, PECAM-1, and CD99). 148 

Expression and/or location changes in claudin−5, occludin, ZO−1, etc. 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 84, 83, 85, 86, 87, 88, 92, 97, 98, 99, 102 Damage to ECs ECs apoptosis, membrane abnormalities, ER stress, and mitochondrial damage.

Upregulation of VCAM−1, ICAM−1, and E-selectin expression in ECs.

Upregulation of α 5 integrin-dependent adhesion. 75

Activation of astrocytes and microglia Astrocytes: increased secretion of VEGF-A. 97, 98, 99, 76 Astrocytes: proliferation, activation, and changes in the end-feet structure.

Microglia: M1 pro-inflammatory microglia; M2 antiinflammatory microglia. 24,26,102,105,25,106,107,108,109,110,111,112 ,113,114,115,116,117,118,119,163 120,121,122,123,124,125 

In addition to the above pathways in which peripheral inflammation affects the BBB, it is demonstrated that morphological changes may not necessarily occur when peripheral inflammation impacts BBB integrity. For instance, TJs may remain intact during inflammation while the functional integrity of the BBB is impaired. 27 Multiple transport pathways are altered by peripheral inflammation. Efflux transporters are downregulated, including P-gp on the astrocytic end-feet, along with those for anions, amino acids, and β-amyloid. Meanwhile, influx transporters are upregulated, including those for insulin, monoamine, and lysosomal enzymes. 27 In addition, the cerebral endothelium expresses IL-1, IL-6, and TNF-α receptors;

thus, these circulating cytokines can directly activate the endothelium, causing BBB dysfunction. 159 This may be associated with nuclear transcription factor IκB. 160 What is more, LPS, TNF-α, and IL-1β can enhance the expression of cyclooxygenase (COX) in the cerebral endothelium. 159 It has been reported that a high dose of LPS causes BBB damage through COX-dependent pathways. 161 Recently, it was identified that dynamic changes of CD antigens, such as CD54 and CD106 in brain vessels, allowed for leukocyte migration with and without alterations of other major functional molecules after LPS injection. 162 

The BBB is a complex CNS structure that precisely regulates the transport of ions, molecules, and cells between the CNS and periphery. It protects the brain from damage and maintains the normal biochemical microenvironment. Peripheral inflammation is one of the comorbid conditions that is involved in BBB breakage and its dysfunction, and its mechanisms are extremely complicated (Table 1) . Take SARS-CoV-2, 

This study was supported by the National Natural Science 

The author declares no conflict of interest.

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Junlei Chang https://orcid.org/0000-0002-0319-9022

The blood-brain barrier

Vasculitis: determinants of disease patterns

Development, maintenance and disruption of the blood-brain barrier

The blood-brain barrier in health and chronic neurodegenerative disorders

Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events

Increasing the permeability of the blood-brain barrier in three different models in vivo

Blood-brain barrier and its function during inflammation and autoimmunity

Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice

Developmental and pathological angiogenesis in the central nervous system

Phenotypic Heterogeneity of the Endothelium: II. Representative vascular beds

Cellular elements of the blood-brain barrier

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration

The molecular constituents of the blood-brain barrier

Central nervous system pericytes in health and disease

Glial regulation of the cerebral microvasculature

Astrocyte-endothelial interactions at the blood-brain barrier

Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity

Pericytes of the neurovascular unit: key functions and signaling pathways

Establishment and Dysfunction of the Blood-Brain Barrier

Pericytes are required for blood-brain barrier integrity during embryogenesis

Multifaceted roles of pericytes in central nervous system homeostasis and disease

The extracellular matrix of the blood-brain barrier: structural and functional roles in health, aging, and Alzheimer's disease. Tissue Barriers

Dual microglia effects on blood brain barrier permeability induced by systemic inflammation

Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia

Tumor necrosis factor-α mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells

The blood-brain barrier in systemic inflammation

Role of the peripheral innate immune system in the development of Alzheimer's disease

Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease

Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model

Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier

Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of parkinson's disease

Collateral damage: contribution of peripheral inflammation to neurodegenerative diseases

Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size

Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters

The peripheral immune response after stroke-A double edge sword for blood-brain barrier integrity

Systemic inflammation in hemorrhagic strokes -A novel neurological sign and therapeutic target?

Adaptive immunity regulation and cerebral ischemia

Immune cells after ischemic stroke onset: roles, migration, and target intervention

miR-98 reduces endothelial dysfunction by protecting blood-brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model

Inhibition of CD147 attenuates stroke-associated pneumonia through modulating lung immune response in mice

The regulation of immunological processes by peripheral neurons in homeostasis and disease

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation

Clinical characteristics of coronavirus disease 2019 in China

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Imbalanced host response to SARS-CoV-2 drives development of COVID-19

COVID-19: consider cytokine storm syndromes and immunosuppression

Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia. 2020;Influencia, de la infeccion SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiatricas: inverted question markuna pandemia demorada

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports

Relapsed childhood acute lymphoblastic leukaemia

The myth of the second remission of acute leukemia in the adult

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Chimeric antigen receptor T cells for sustained remissions in leukemia

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Phase 1 results of ZUMA-1: a multicenter study of KTE-C19 Anti-CD19 CAR T cell therapy in refractory aggressive lymphoma

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Neurotoxicity associated with CD19-targeted CAR-T cell therapies

Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells

Chimeric antigen receptor T cell-related neurotoxicity: mechanisms, clinical presentation, and approach to treatment

Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies

Prospective study on the relationship between infections and multiple sclerosis exacerbations

Systemic inflammation and disease progression in Alzheimer disease

Innate immunity cells and the neurovascular unit

Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells

Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

IL-1beta promotes transendothelial migration of PBMCs by upregulation of the FN/alpha5beta1 signalling pathway in immortalised human brain microvascular endothelial cells

Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A

Interleukin-1beta induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model

Social stress induces neurovascular pathology promoting depression

Propofol improved hypoxia-impaired integrity of blood-brain barrier via modulating the expression and phosphorylation of zonula occludens-1

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

Melatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice

Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury

Mice with pre-existing tumors are vulnerable to postoperative cognitive dysfunction

LPS induces occludin dysregulation in cerebral microvascular endothelial cells via MAPK signaling and augmenting MMP-2 Levels

Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier

Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20

Blood-brain barrier dysfunction induced by silica NPs in vitro and in vivo: involvement of oxidative stress and Rho-kinase/JNK signaling pathways

Poldip2 mediates blood-brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model

Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells

2-Chlorohexadecanoic acid induces ER stress and mitochondrial dysfunction in brain microvascular endothelial cells

Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNK

Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice

Vascular inflammation is a risk factor associated with brain atrophy and disease severity in parkinson's disease: a case-control study

Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1

Physical exercise attenuates experimental autoimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption

Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

VEGFmediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier

Systemic immune activation leads to neuroinflammation and sickness behavior in mice

Genomic analysis of reactive astrogliosis

The impact of microglial activation on blood-brain barrier in brain diseases

Treatment targets for M2 microglia polarization in ischemic stroke

Aging alters Hv1-mediated microglial polarization and enhances neuroinflammation after peripheral surgery

Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats

The role of the immunoproteasome in interferon-γ-mediated microglial activation

GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease

Chronic depletion of gonadal testosterone leads to blood-brain barrier dysfunction and inflammation in male mice

Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia

Hypertonic saline mediates the NLRP3/IL-1β signaling axis in microglia to alleviate ischemic blood-brain barrier permeability by downregulating astrocyte-derived VEGF in rats

Autocrine activation of microglia by tumor necrosis factor-α

Group A streptococcus subcutaneous infection-induced central nervous system inflammation is attenuated by blocking peripheral TNF

Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier

Inhibiting the migration of M1 microglia at hyperacute period could improve outcome of tMCAO rats

CX3CR1-CCR2-dependent monocyte-microglial signaling modulates neurovascular leakage and acute injury in a mouse model of childhood stroke

Systemic inflammation induces axon injury during brain inflammation

Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke

Targeting microglial activation states as a therapeutic avenue in Parkinson's disease

Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway

Effects of ischemic post-conditioning on neuronal VEGF regulation and microglial polarization in a rat model of focal cerebral ischemia

Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective

TGFβ signalling plays an important role in IL4-induced alternative activation of microglia

Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood-brain barrier: understanding transport mechanisms for improved cns drug delivery?

Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia/macrophage polarization through the IL-10/ GSK3β/PTEN axis

Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions

Role of bone marrow-derived macrophages (BMDMs) in neurovascular interactions during stroke

Inflammation in CNS neurodegenerative diseases

N-myc downstream-regulated gene 2 protects blood-brain barrier integrity following cerebral ischemia

Up-regulation of brain cytokines and metalloproteinases 1 and 2 contributes to neurological deficit and brain damage in transient ischemic stroke

Invasion of peripheral immune cells into brain parenchyma after cardiac arrest and resuscitation

Differentiation and transmigration of CD4 T cells in neuroinflammation and autoimmunity

Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis

Stroke and T-cells

Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke

Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

IL-2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8(+) T cells

Experimental ischemic stroke induces long-term T cell activation in the brain

Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers

Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system

Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis

Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10

Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases

Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia

Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke

Myeloid cell transmigration across the CNS vasculature triggers IL-1beta-driven neuroinflammation during autoimmune encephalomyelitis in mice

Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice

Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis

JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals

Frontline Science: buprenorphine decreases CCL2-mediated migration of CD14(+) CD16(+) monocytes

Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis

Myeloid cells -targets of medication in multiple sclerosis

Brain perivascular macrophages: Recent advances and implications in health and diseases

A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2

Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia

Potential immunotherapeutic targets on myeloid cells for neurovascular repair after ischemic stroke

The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke

A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1Β, TNF-α and IL-6 challenges in C57BL/6 mice

Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus

Lipopolysaccharideinduced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit

Selective protein expression changes of leukocyte-migration-associated cluster of differentiation antigens at the blood-brain barrier in a lipopolysaccharide-induced systemic inflammation mouse model without alteration of transporters, receptors or tight junction-related protein

Microglial priming as trained immunity in the brain

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell Lymphoma

Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms